Reliability of the Dexcom G6 Continuous Glucose Monitor during Hyperbaric Oxygen Exposure

Enoch Huang, Shaban Demirel, Chanelle Bliss, Davut Savaser, Jessica R. Castle

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Background: People with diabetes-related ulcers may benefit from hyperbaric oxygen (HBO2) therapy and from continuous glucose monitors (CGM). Although blood glucose (BG) meters based on glucose oxidase (GO) report erroneously low values at high pO2, BG meters based on glucose dehydrogenase (GD) do not. We therefore examined the performance of a GO-based CGM system in comparison to GO-based and GD-based BG systems in normobaric air (NBAir), hyperbaric air (HBAir), and HBO2 environments. Materials and Methods: Twenty-six volunteers without diabetes mellitus (DM) wore Dexcom G6 CGM systems and provided periodic blood samples before, during, and after a standard HBO2 treatment consisting of three 30-min intervals of HBO2 separated by two 5-min intervals of HBAir. Accuracy of the CGM and GO-based BG meter were assessed by comparisons with the GD-based values. Results: The mean absolute relative difference for the CGM system was 15.96% and for the GO-based meter was 8.52%. Compared to NBAir, HBO2 exposure resulted in significantly higher CGM values (+3.76 mg/dL, P < 0.001) and significantly lower GO-based meter values (-10.38 mg/dL, P < 0.001). Pre-HBO2 and post-HBO2 values obtained in NBAir were also significantly different when measured by CGM (+4.13 mg/dL, P = 0.015) or the GO-based meter (-9.04 mg/dL, P < 0.001). Conclusions: In volunteers without DM, HBO2 exposure results in statistically significant differences in glucose measurements obtained with GO-based devices, but not a GD-based device. Standard HBO2 treatment results in statistically significant effects on glucose concentrations. These differences are of unlikely clinical significance.

Original languageEnglish (US)
Pages (from-to)360-366
Number of pages7
JournalDiabetes Technology and Therapeutics
Issue number5
StatePublished - May 1 2020


  • Continuous glucose monitors (CGM)
  • HBO
  • Hyperbaric oxygen therapy
  • Hypoglycemia

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology


Dive into the research topics of 'Reliability of the Dexcom G6 Continuous Glucose Monitor during Hyperbaric Oxygen Exposure'. Together they form a unique fingerprint.

Cite this